UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
|
||
WASHINGTON, D.C. 20549
|
||
SCHEDULE 13D
|
||
(AMENDMENT NO. 2)
|
||
UNDER THE SECURITIES ACT OF 1934
|
||
Evofem Biosciences, Inc.
|
||
(Name of Issuer)
|
||
Common Stock, $0.0001 par value per share
|
||
(Title and Class of Securities)
|
||
30048L104
|
||
(CUSIP Number)
|
||
Nancy Tomassone
|
||
Invesco Ltd.
|
||
1555 Peachtree Street, N.E., Suite 1800
|
||
Atlanta, Georgia 30309
|
||
Telephone number: (404) 892-0896
|
||
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
|
||
February 8, 2019
|
||
(Date of Event which Requires Filing of this Statement)
|
1
|
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Invesco Ltd.
IRS# 980557567 |
|||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐
(b) ☐ |
|
||
3
|
SEC USE ONLY
|
|||
4
|
SOURCE OF FUNDS
OO
|
|||
5
|
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2 (d) ☐
OR
2 (e) ☐
|
|||
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
|
|||
NUMBER OF
SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
7
|
SOLE VOTING POWER
9,590,688
|
||
8
|
SHARED VOTING POWER
0
|
|||
9
|
SOLE DISPOSITIVE POWER
9,590,688
|
|||
10
|
SHARED DISPOSITIVE POWER
0
|
|||
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,590,688
|
|||
12
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
|
|||
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
33.4%*
|
|||
14
|
TYPE OF REPORTING PERSON
HC, IA
|
|||
* Based on total outstanding shares of 28,718,310.
|
99.4
|
Letter Agreement, dated February 5, 2019, between Evofem Biosciences, Inc. and Invesco Ltd. including Form of Warrant.
|
Dated: February 12, 2019
|
||
INVESCO LTD.
|
||
By:
|
/s/ Nancy Tomassone
|
|
Name: Nancy Tomassone
|
||
Title: Global Assurance Officer
|